This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sarepta Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $13.376. Sarepta Therapeutics's 10-Year median PS Ratio is 29.1328. Therefore, the Median PS Value for today is $389.68.
As of today (2024-04-24), Sarepta Therapeutics's share price is $124.25. Sarepta Therapeutics's Median PS Value is $389.68. Therefore, Sarepta Therapeutics's Price to Median PS Value for today is 0.32.
The historical rank and industry rank for Sarepta Therapeutics's Median PS Value or its related term are showing as below:
SRPT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.25 Med: 0.8 Max: 96.45
Current: 0.32
During the past 13 years, the highest Price to Median PS Value of Sarepta Therapeutics was 96.45. The lowest was 0.25. And the median was 0.80.
SRPT's Price-to-Median-PS-Value is ranked better than 79.46% of 258
companies
in the Biotechnology industry
Industry Median: 0.66
vs SRPT: 0.32
Sarepta Therapeutics Median PS Value Historical Data
The historical data trend for Sarepta Therapeutics's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sarepta Therapeutics's Median PS Value
For the Biotechnology subindustry, Sarepta Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sarepta Therapeutics's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sarepta Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sarepta Therapeutics's Price-to-Median-PS-Value falls into.
Sarepta Therapeutics Median PS Value Calculation
Sarepta Therapeutics's Median PS Value for today is calculated as
10-Year Median PS Ratio is 29.1328.
Sarepta Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.376.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sarepta Therapeutics (NAS:SRPT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sarepta Therapeutics's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
124.25
/
389.68
=
0.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sarepta Therapeutics Median PS Value Related Terms
Thank you for viewing the detailed overview of Sarepta Therapeutics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Sarepta Therapeutics (Sarepta Therapeutics) Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SRPT has been successfully added to your 